THERAPIES
-
CHS survey of people with hemophilia A and their caregivers
In June and July 2024, the Canadian Hemophilia Society conducted an online survey regarding the lived experience of people with hemophilia A and their caregivers....
-
Novel treatments in bleeding disorders: The European Haemophilia Consortium Review
CLICK HERE to access the 2024 ISSUE TWO of the periodic review of novel treatments in hemophilia and other bleeding disorders by the European Haemophilia...
-
The Care and Treatment Committee … essential to the maintenance and improvement of comprehensive care in Canada
PREAMBLE In our special series of articles on the numerous committees our volunteers sit on, it is our pleasure to now present you the Care...
-
WFH World Congress: so much to learn in so little time!
For many years I coordinated the publication of articles written by participants who had attended the WFH World Congresses for the CHS newsmagazine, Hemophilia Today....
-
Conflicting opinions on gene therapies from Canada’s two HTA agencies
Montreal, July 5, 2024 – Canada’s two health technology assessment (HTA) agencies have made conflicting recommendations on two gene therapies for hemophilia B. Earlier in...